Page last updated: 2024-12-05

lavendustin b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Lavendustin B is a natural product isolated from the fungus Aspergillus terreus. It is a potent inhibitor of protein tyrosine kinases, enzymes that play a key role in cell signaling. Lavendustin B has been shown to have a variety of biological activities, including anti-cancer, anti-inflammatory, and anti-angiogenic effects. It is currently being investigated as a potential therapeutic agent for a variety of diseases. Lavendustin B is a promising lead compound for the development of new drugs targeting protein tyrosine kinases. It has shown promising results in preclinical studies and is currently being evaluated in clinical trials.'

Cross-References

ID SourceID
PubMed CID3895
CHEMBL ID485258
SCHEMBL ID13228056
MeSH IDM0243969

Synonyms (34)

Synonym
unii-7t53egq52z
benzoic acid, 5-(bis((2-hydroxyphenyl)methyl)amino)-2-hydroxy-
7t53egq52z ,
5-(bis((2-hydroxyphenyl)methyl)amino)-2-hydroxybenzoic acid
BRD-K33781562-001-02-7
HSCI1_000118
SMP2_000233
NCGC00163670-01
lavendustin b
125697-91-8
CHEMBL485258
5-[bis[(2-hydroxyphenyl)methyl]amino]-2-hydroxybenzoic acid
FT-0627735
CCG-208626
5-[bis[(2-hydroxyphenyl)methyl]amino]-2-hydroxy-benzoic acid
SCHEMBL13228056
DTXSID40154854
J-005264
bdbm50025606
AKOS030239802
SR-05000002160-2
sr-05000002160
BCP20779
5-(bis(2-hydroxybenzyl)amino)-2-hydroxybenzoic acid
5-amino-(n,n'-bis-2-hydroxybenzyl)salicylic acid
tert-butyl4-(hydroxyimino)piperidine-1-carboxylate
N17046
benzoic acid, 5-[bis[(2-hydroxyphenyl)methyl]amino]-2-hydroxy-
Q27268819
BS-49228
n,n-bis(2'-hydroxybenzyl)-3-aminosalicylic acid
HY-108935
CS-0032024
L0312
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (12)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency19.95260.003245.467312,589.2998AID2517
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency19.90540.140911.194039.8107AID2451
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency50.11870.631035.7641100.0000AID504339
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency44.10730.125919.1169125.8920AID2549; AID504841
thioredoxin reductaseRattus norvegicus (Norway rat)Potency39.81070.100020.879379.4328AID588453
phosphopantetheinyl transferaseBacillus subtilisPotency56.23410.141337.9142100.0000AID1490
regulator of G-protein signaling 4Homo sapiens (human)Potency70.79460.531815.435837.6858AID504845
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency79.43280.354828.065989.1251AID504847
flap endonuclease 1Homo sapiens (human)Potency22.38720.133725.412989.1251AID588795
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency15.84890.425612.059128.1838AID504891
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency14.12540.050127.073689.1251AID588590
DNA polymerase kappa isoform 1Homo sapiens (human)Potency44.66840.031622.3146100.0000AID588579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID771477Inhibition of HIV1 His6-tagged integrase-LEDGF/p75 (unknown origin) interaction at 100 uM incubated for 30 mins followed by LEDGF/p75 addition measured after 4 hrs relative to control2013European journal of medicinal chemistry, Oct, Volume: 68New scaffolds of natural origin as Integrase-LEDGF/p75 interaction inhibitors: virtual screening and activity assays.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID771476Inhibition of HIV1 His6-tagged integrase-LEDGF/p75 (unknown origin) interaction incubated for 30 mins followed by LEDGF/p75 addition measured after 4 hrs2013European journal of medicinal chemistry, Oct, Volume: 68New scaffolds of natural origin as Integrase-LEDGF/p75 interaction inhibitors: virtual screening and activity assays.
AID337238Inhibition of mouse EGFR by liquid scintillation counting
AID358171Inhibition of EGFR in human A431 cells1992Journal of natural products, Nov, Volume: 55, Issue:11
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (35.71)18.2507
2000's3 (21.43)29.6817
2010's4 (28.57)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.83 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]